SRC and breast cancer: In addition, CCL18-induced increases in breast cancer cell (MDA-MB-231) migration, accompanied by the activation of PyK2 and Src [80], whereas CCL18-induced cell migration was attenuated by siRNA-PyK2 and siRNA-Src [80].